The state of the Osteoarthritis Initiative (OAI): Entering a new era
- PMID: 41308296
- PMCID: PMC12710767
- DOI: 10.1016/j.semarthrit.2025.152887
The state of the Osteoarthritis Initiative (OAI): Entering a new era
Keywords: Biobanking; Biomarkers; Cohort studies; Knee osteoarthritis; Magnetic resonance imaging; Radiography.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jeffrey Driban reports financial support was provided by National Institutes of Health. Timothy McAlindon reports a relationship with Sanofi that includes: consulting or advisory. Timothy McAlindon reports a relationship with Kolon TissueGene that includes: consulting or advisory. Timothy McAlindon reports a relationship with Medidata that includes: consulting or advisory. Timothy McAlindon reports a relationship with Organogenesis Inc that includes: consulting or advisory. Timothy McAlindon reports a relationship with Ambulomics that includes: equity or stocks. Timothy McAlindon reports a relationship with Arthrometrics that includes: equity or stocks. Jeffrey Driban and Timothy McAlindon has patent Objective Assessment of Joint Damage; Patent No 12,307,671; 2025. issued to Tufts Medical Center, Inc and Trustees of Boston University. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
